Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
34
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Mims David W. | Interim CEO and Interim CFO | 4 | $0 | $0 | 2020-06-19 |
| Maeusli Heinz Christoph | Director | 4 | $0 | $0 | 2020-06-19 |
| Ber Gerard | Director | 5 | $0 | $0 | 2020-06-19 |
| Osorio Benedict | Senior Vice President, Quality | 7 | $0 | $0 | 2020-06-19 |
| Das Asha | Chief Medical Officer | 4 | $0 | $0 | 2020-06-19 |
| MacDougall Ann L. | Director | 4 | $0 | $0 | 2020-06-19 |
| Tenbarge Bryce | Vice President, Commercial | 10 | $0 | $0 | 2020-06-19 |
| Wong Vivien | Executive Vice President | 19 | $0 | $0 | 2020-06-19 |
| Ferrante Karen Jean | Director | 14 | $0 | $0 | 2020-06-19 |
| Ende Eric J | Director | 4 | $0 | $0 | 2020-06-19 |
| Campbell Bradley L | Director | 11 | $0 | $0 | 2020-06-19 |
| Fabbio Patrick | CFO | 6 | $0 | $0 | 2020-03-02 |
| LTE Management, LLC | 10% Owner | 2 | $307.2K | $0 | 2019-09-09 |
| Altiva Management Inc. | 10% Owner | 1 | $359.4K | $0 | 2019-09-09 |
| Velan Capital, L.P. | 10% Owner | 2 | $2.32M | $0 | 2019-09-04 |
| VENKATARAMAN BALAJI | 10% Owner | 2 | $878.7K | $0 | 2019-08-26 |
| Crowley Peter J | Director | 12 | $0 | $0 | 2019-07-11 |
| SCHEINBERG DAVID A | Director | 17 | $0 | $12.5K | 2019-07-11 |
| WILLIAMS NICOLE | Director | 8 | $0 | $0 | 2019-07-11 |
| KISHBAUCH MICHAEL D | Director | 8 | $0 | $0 | 2019-07-11 |
| Baker Mark Robert | Chief Executive Officer | 59 | $255.1K | $0 | 2019-03-01 |
| Summer Jeffery | Senior VP, Strategy and Perfor | 2 | $0 | $0 | 2018-03-01 |
| Broadfin Capital, LLC | 10% Owner | 12 | $0 | $9.23M | 2017-02-15 |
| Hirt Sheldon | Executive VP & General Counsel | 2 | $0 | $0 | 2016-03-01 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 56 | $0 | $378.9K | 2015-06-11 |
| MADDON PAUL J | Director | 5 | $24.5K | $0 | 2015-06-10 |
| Lovallo Angelo William JR | Vice President Finance | 2 | $0 | $0 | 2015-03-02 |
| KOTLER KEVIN | 10% Owner | 4 | $7.48M | $0 | 2014-07-21 |
| Youssoufian Hagop | Executive Vice President R&D | 2 | $0 | $0 | 2014-03-03 |
| GOFF STEPHEN P | Director | 2 | $0 | $0 | 2013-06-12 |
| Olson William C | Senior VP, Research and Develo | 3 | $0 | $0 | 2013-04-04 |
| BRINER KURT W | Director | 2 | $0 | $337.3K | 2012-06-13 |
| BAKER CHARLES A | Director | 1 | $0 | $0 | 2012-06-13 |
| MCKINNEY ROBERT A | Senior VP, CFO | 1 | $0 | $0 | 2012-03-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Maeusli Heinz Christoph | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 40,000 | — | $0 | 0 | SEC↗ |
| Maeusli Heinz Christoph | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 16,393 | — | $0 | 0 | SEC↗ |
| MacDougall Ann L. | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 36,065 | — | $0 | 0 | SEC↗ |
| MacDougall Ann L. | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 40,000 | — | $0 | 0 | SEC↗ |
| Ferrante Karen Jean | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 20,000 | — | $0 | 0 | SEC↗ |
| Ferrante Karen Jean | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 40,000 | — | $0 | 0 | SEC↗ |
| Ferrante Karen Jean | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 25,000 | — | $0 | 0 | SEC↗ |
| Ferrante Karen Jean | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 25,000 | — | $0 | 0 | SEC↗ |
| Ferrante Karen Jean | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 20,000 | — | $0 | 0 | SEC↗ |
| Ferrante Karen Jean | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 20,000 | — | $0 | 0 | SEC↗ |
| Ferrante Karen Jean | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 20,000 | — | $0 | 0 | SEC↗ |
| Ende Eric J | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 40,000 | — | $0 | 0 | SEC↗ |
| Ende Eric J | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 16,393 | — | $0 | 0 | SEC↗ |
| Campbell Bradley L | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 25,000 | — | $0 | 0 | SEC↗ |
| Campbell Bradley L | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 25,000 | — | $0 | 0 | SEC↗ |
| Campbell Bradley L | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 28,000 | — | $0 | 0 | SEC↗ |
| Campbell Bradley L | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 20,000 | — | $0 | 0 | SEC↗ |
| Ber Gerard | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 16,393 | — | $0 | 0 | SEC↗ |
| Ber Gerard | Director | D To issuer deriv | 2020-06-19 | 2020-06-23 | 40,000 | — | $0 | 0 | SEC↗ |
| Mims David W. | Interim CEO and Interim CFO | D To issuer deriv | 2020-06-19 | 2020-06-23 | 40,000 | — | $0 | 0 | SEC↗ |
| Mims David W. | Interim CEO and Interim CFO | D To issuer deriv | 2020-06-19 | 2020-06-23 | 16,393 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 82,214 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 90,750 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 94,875 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 82,500 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 82,500 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 66,000 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 75,000 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 52,800 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 48,000 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 6,000 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 25,000 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 40,000 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer deriv | 2020-06-19 | 2020-06-23 | 60,000 | — | $0 | 0 | SEC↗ |
| Tenbarge Bryce | SVP, Commercial | D To issuer deriv | 2020-06-19 | 2020-06-23 | 90,750 | — | $0 | 0 | SEC↗ |
| Tenbarge Bryce | SVP, Commercial | D To issuer deriv | 2020-06-19 | 2020-06-23 | 75,000 | — | $0 | 0 | SEC↗ |
| Tenbarge Bryce | SVP, Commercial | D To issuer deriv | 2020-06-19 | 2020-06-23 | 66,000 | — | $0 | 0 | SEC↗ |
| Tenbarge Bryce | SVP, Commercial | D To issuer deriv | 2020-06-19 | 2020-06-23 | 75,900 | — | $0 | 0 | SEC↗ |
| Tenbarge Bryce | SVP, Commercial | D To issuer deriv | 2020-06-19 | 2020-06-23 | 82,214 | — | $0 | 0 | SEC↗ |
| Osorio Benedict | COO | D To issuer deriv | 2020-06-19 | 2020-06-23 | 90,750 | — | $0 | 0 | SEC↗ |
| Osorio Benedict | COO | D To issuer deriv | 2020-06-19 | 2020-06-23 | 100,000 | — | $0 | 0 | SEC↗ |
| Osorio Benedict | COO | D To issuer deriv | 2020-06-19 | 2020-06-23 | 82,214 | — | $0 | 0 | SEC↗ |
| Das Asha | Chief Medical Officer | D To issuer deriv | 2020-06-19 | 2020-06-23 | 82,214 | — | $0 | 0 | SEC↗ |
| Das Asha | Chief Medical Officer | D To issuer deriv | 2020-06-19 | 2020-06-23 | 125,000 | — | $0 | 0 | SEC↗ |
| Campbell Bradley L | Director | D To issuer | 2020-06-19 | 2020-06-23 | 12,000 | — | $0 | 0 | SEC↗ |
| Ber Gerard | Director | D To issuer | 2020-06-19 | 2020-06-23 | 50,000 | — | $0 | 0 | SEC↗ |
| Wong Vivien | EVP, Development | D To issuer | 2020-06-19 | 2020-06-23 | 4,121 | — | $0 | 0 | SEC↗ |
| Osorio Benedict | COO | D To issuer | 2020-06-19 | 2020-06-23 | 21,202 | — | $0 | 0 | SEC↗ |
| Fabbio Patrick | CFO | A Award deriv | 2020-03-02 | 2020-03-04 | 82,214 | — | $0 | 82,214 | SEC↗ |
| Tenbarge Bryce | SVP, Commercial | A Award deriv | 2020-03-02 | 2020-03-04 | 82,214 | — | $0 | 82,214 | SEC↗ |
| Wong Vivien | EVP, Development | A Award deriv | 2020-03-02 | 2020-03-04 | 82,214 | — | $0 | 82,214 | SEC↗ |
| Osorio Benedict | COO | A Award deriv | 2020-03-02 | 2020-03-04 | 82,214 | — | $0 | 82,214 | SEC↗ |
| Das Asha | Chief Medical Officer | A Award deriv | 2020-03-02 | 2020-03-04 | 82,214 | — | $0 | 82,214 | SEC↗ |
| Ber Gerard | Director | A Award deriv | 2019-12-13 | 2019-12-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Ber Gerard | Director | A Award deriv | 2019-12-13 | 2019-12-17 | 16,393 | — | $0 | 16,393 | SEC↗ |
| Ende Eric J | Director | A Award deriv | 2019-12-13 | 2019-12-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Ende Eric J | Director | A Award deriv | 2019-12-13 | 2019-12-17 | 16,393 | — | $0 | 16,393 | SEC↗ |
| MacDougall Ann L. | Director | A Award deriv | 2019-12-13 | 2019-12-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MacDougall Ann L. | Director | A Award deriv | 2019-12-13 | 2019-12-17 | 36,065 | — | $0 | 36,065 | SEC↗ |
| Mims David W. | Director | A Award deriv | 2019-12-13 | 2019-12-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Mims David W. | Director | A Award deriv | 2019-12-13 | 2019-12-17 | 16,393 | — | $0 | 16,393 | SEC↗ |
| Maeusli Heinz Christoph | Director | A Award deriv | 2019-12-13 | 2019-12-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Maeusli Heinz Christoph | Director | A Award deriv | 2019-12-13 | 2019-12-17 | 16,393 | — | $0 | 16,393 | SEC↗ |
| LTE Management, LLC | 10% Owner | P Buy | 2019-09-09 | 2019-09-09 | 21,480 | $4.94 | $106.1K | 1,950,000 | SEC↗ |
| Altiva Management Inc. | 10% Owner | P Buy | 2019-09-09 | 2019-09-11 | 72,023 | $4.99 | $359.4K | 8,011,733 | SEC↗ |
| LTE Management, LLC | 10% Owner | P Buy | 2019-09-05 | 2019-09-09 | 43,520 | $4.62 | $201.1K | 1,928,520 | SEC↗ |
| Velan Capital, L.P. | 10% Owner | P Buy | 2019-09-04 | 2019-09-05 | 243,614 | $4.51 | $1.10M | 7,939,710 | SEC↗ |
| Velan Capital, L.P. | 10% Owner | P Buy | 2019-09-03 | 2019-09-05 | 277,424 | $4.39 | $1.22M | 7,696,096 | SEC↗ |
| VENKATARAMAN BALAJI | 10% Owner | P Buy | 2019-08-26 | 2019-08-27 | 73,230 | $4.30 | $314.9K | 7,418,672 | SEC↗ |
| VENKATARAMAN BALAJI | 10% Owner | P Buy | 2019-08-23 | 2019-08-27 | 130,826 | $4.31 | $563.9K | 7,345,442 | SEC↗ |
| Campbell Bradley L | Director | A Award deriv | 2019-07-11 | 2019-07-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Crowley Peter J | Director | A Award deriv | 2019-07-11 | 2019-07-15 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Ferrante Karen Jean | Director | A Award deriv | 2019-07-11 | 2019-07-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2019-07-11 | 2019-07-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SCHEINBERG DAVID A | Director | A Award deriv | 2019-07-11 | 2019-07-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| WILLIAMS NICOLE | Director | A Award deriv | 2019-07-11 | 2019-07-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Campbell Bradley L | Director | M Exercise deriv | 2019-07-03 | 2019-07-08 | 12,000 | — | $0 | 0 | SEC↗ |
| Campbell Bradley L | Director | M Exercise | 2019-07-03 | 2019-07-08 | 12,000 | $4.89 | $58.7K | 12,000 | SEC↗ |
| SCHEINBERG DAVID A | Director | M Exercise deriv | 2019-07-01 | 2019-07-03 | 10,000 | — | $0 | 0 | SEC↗ |
| SCHEINBERG DAVID A | Director | M Exercise | 2019-07-01 | 2019-07-03 | 10,000 | $5.33 | $53.3K | 56,185 | SEC↗ |
| Crowley Peter J | Director | M Exercise deriv | 2019-06-26 | 2019-06-27 | 40,000 | — | $0 | 0 | SEC↗ |
| Crowley Peter J | Director | M Exercise deriv | 2019-06-26 | 2019-06-27 | 10,000 | — | $0 | 0 | SEC↗ |
| Crowley Peter J | Director | M Exercise | 2019-06-26 | 2019-06-27 | 40,000 | $5.35 | $214.0K | 50,000 | SEC↗ |
| Crowley Peter J | Director | M Exercise | 2019-06-26 | 2019-06-27 | 10,000 | $5.33 | $53.3K | 10,000 | SEC↗ |
| Baker Mark Robert | Chief Executive Officer | A Award deriv | 2019-03-01 | 2019-03-05 | 192,500 | — | $0 | 192,500 | SEC↗ |
| Wong Vivien | EVP, Development | A Award deriv | 2019-03-01 | 2019-03-05 | 90,750 | — | $0 | 90,750 | SEC↗ |
| Tenbarge Bryce | SVP, Commercial | A Award deriv | 2019-03-01 | 2019-03-05 | 90,750 | — | $0 | 90,750 | SEC↗ |
| Fabbio Patrick | CFO | A Award deriv | 2019-03-01 | 2019-03-05 | 90,750 | — | $0 | 90,750 | SEC↗ |
| Osorio Benedict | Senior Vice President, Quali | A Award deriv | 2019-03-01 | 2019-03-05 | 90,750 | — | $0 | 90,750 | SEC↗ |
| Das Asha | Chief Medical Officer | A Award deriv | 2019-02-01 | 2019-02-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Campbell Bradley L | Director | A Award deriv | 2018-06-13 | 2018-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Crowley Peter J | Director | A Award deriv | 2018-06-13 | 2018-06-14 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Ferrante Karen Jean | Director | A Award deriv | 2018-06-13 | 2018-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2018-06-13 | 2018-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SCHEINBERG DAVID A | Director | A Award deriv | 2018-06-13 | 2018-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| WILLIAMS NICOLE | Director | A Award deriv | 2018-06-13 | 2018-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Baker Mark Robert | Chief Executive Officer | A Award deriv | 2018-03-01 | 2018-03-02 | 201,250 | — | $0 | 201,250 | SEC↗ |
| Fabbio Patrick | CFO | A Award deriv | 2018-03-01 | 2018-03-02 | 94,875 | — | $0 | 94,875 | SEC↗ |
| Tenbarge Bryce | SVP, Commercial | A Award deriv | 2018-03-01 | 2018-03-02 | 75,900 | — | $0 | 75,900 | SEC↗ |
| Summer Jeffery | SVP, Digital Technology | A Award deriv | 2018-03-01 | 2018-03-02 | 94,875 | — | $0 | 94,875 | SEC↗ |
| Wong Vivien | EVP, Development | A Award deriv | 2018-03-01 | 2018-03-02 | 94,875 | — | $0 | 94,875 | SEC↗ |
| Osorio Benedict | Senior Vice President, Quali | A Award deriv | 2018-03-01 | 2018-03-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2017-06-14 | 2017-06-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| WILLIAMS NICOLE | Director | A Award deriv | 2017-06-14 | 2017-06-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SCHEINBERG DAVID A | Director | A Award deriv | 2017-06-14 | 2017-06-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Crowley Peter J | Director | A Award deriv | 2017-06-14 | 2017-06-15 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Ferrante Karen Jean | Director | A Award deriv | 2017-06-14 | 2017-06-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Campbell Bradley L | Director | A Award deriv | 2017-06-14 | 2017-06-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Fabbio Patrick | CFO | A Award deriv | 2017-03-01 | 2017-03-07 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Summer Jeffery | Senior VP, Strategy and Perf | A Award deriv | 2017-03-01 | 2017-03-07 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Tenbarge Bryce | Vice President, Commercial | A Award deriv | 2017-03-01 | 2017-03-07 | 66,000 | — | $0 | 66,000 | SEC↗ |
| Wong Vivien | Executive Vice President | A Award deriv | 2017-03-01 | 2017-03-07 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Baker Mark Robert | Chief Executive Officer | A Award deriv | 2017-03-01 | 2017-03-07 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Broadfin Capital, LLC | 10% Owner | S Sale | 2017-02-15 | 2017-02-15 | 150,000 | $9.55 | $1.43M | 6,997,269 | SEC↗ |
| Broadfin Capital, LLC | 10% Owner | S Sale | 2017-02-14 | 2017-02-15 | 52,600 | $9.70 | $510.2K | 7,447,269 | SEC↗ |
| Broadfin Capital, LLC | 10% Owner | S Sale | 2017-02-14 | 2017-02-15 | 150,000 | $9.68 | $1.45M | 7,147,269 | SEC↗ |
| Broadfin Capital, LLC | 10% Owner | S Sale | 2017-02-14 | 2017-02-15 | 50,000 | $9.70 | $485.0K | 7,397,269 | SEC↗ |
| Broadfin Capital, LLC | 10% Owner | S Sale | 2017-02-14 | 2017-02-15 | 100,000 | $9.70 | $970.0K | 7,297,269 | SEC↗ |
| Broadfin Capital, LLC | 10% Owner | S Sale | 2017-02-13 | 2017-02-15 | 100,000 | $9.70 | $970.0K | 7,499,869 | SEC↗ |
| Broadfin Capital, LLC | 10% Owner | S Sale | 2017-02-09 | 2017-02-09 | 1,300 | $9.69 | $12.6K | 7,599,869 | SEC↗ |
| Broadfin Capital, LLC | 10% Owner | S Sale | 2017-02-09 | 2017-02-09 | 100,000 | $9.66 | $966.0K | 7,601,169 | SEC↗ |
| Broadfin Capital, LLC | 10% Owner | S Sale | 2017-02-09 | 2017-02-09 | 100,000 | $9.75 | $975.0K | 7,701,169 | SEC↗ |
| Broadfin Capital, LLC | 10% Owner | S Sale | 2017-02-07 | 2017-02-09 | 100,000 | $9.74 | $974.0K | 7,851,169 | SEC↗ |
| Broadfin Capital, LLC | 10% Owner | S Sale | 2017-02-07 | 2017-02-09 | 50,000 | $9.65 | $482.5K | 7,801,169 | SEC↗ |
| Broadfin Capital, LLC | 10% Owner | D To issuer | 2017-01-11 | 2017-01-13 | 1,000,000 | $8.95 | $8.95M | 7,951,169 | SEC↗ |
| Tenbarge Bryce | Vice President, Commercial | A Award deriv | 2016-10-03 | 2016-10-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2016-06-08 | 2016-06-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Ferrante Karen Jean | Director | A Award deriv | 2016-06-08 | 2016-06-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Crowley Peter J | Director | A Award deriv | 2016-06-08 | 2016-06-09 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Campbell Bradley L | Director | A Award deriv | 2016-06-08 | 2016-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SCHEINBERG DAVID A | Director | A Award deriv | 2016-06-08 | 2016-06-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| WILLIAMS NICOLE | Director | A Award deriv | 2016-06-08 | 2016-06-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Baker Mark Robert | CEO | A Award deriv | 2016-03-01 | 2016-03-03 | 175,000 | $4.52 | $791.0K | 175,000 | SEC↗ |
| Fabbio Patrick | CFO | A Award deriv | 2016-03-01 | 2016-03-03 | 82,500 | $4.52 | $372.9K | 82,500 | SEC↗ |
| Hirt Sheldon | Executive VP & General Couns | A Award deriv | 2016-03-01 | 2016-03-03 | 82,500 | $4.52 | $372.9K | 82,500 | SEC↗ |
| Wong Vivien | Executive Vice President | A Award deriv | 2016-03-01 | 2016-03-03 | 82,500 | $4.52 | $372.9K | 82,500 | SEC↗ |
| Fabbio Patrick | CFO | A Award deriv | 2015-12-01 | 2015-12-03 | 125,000 | $6.77 | $846.3K | 125,000 | SEC↗ |
| Hirt Sheldon | Executive VP & General Couns | A Award deriv | 2015-08-03 | 2015-08-05 | 125,000 | $8.56 | $1.07M | 125,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise deriv | 2015-06-11 | 2015-06-15 | 2,000 | $6.83 | $13.7K | 4,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | S Sale | 2015-06-11 | 2015-06-15 | 2,000 | $6.83 | $13.7K | 35,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise | 2015-06-11 | 2015-06-15 | 2,000 | $5.33 | $10.7K | 37,050 | SEC↗ |
| Crowley Peter J | Director | A Award deriv | 2015-06-10 | 2015-06-11 | 55,000 | $6.72 | $369.6K | 55,000 | SEC↗ |
| Ferrante Karen Jean | Director | A Award deriv | 2015-06-10 | 2015-06-11 | 20,000 | $6.72 | $134.4K | 20,000 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2015-06-10 | 2015-06-11 | 20,000 | $6.72 | $134.4K | 20,000 | SEC↗ |
| MADDON PAUL J | Director | A Award deriv | 2015-06-10 | 2015-06-11 | 20,000 | $6.72 | $134.4K | 20,000 | SEC↗ |
| SCHEINBERG DAVID A | Director | A Award deriv | 2015-06-10 | 2015-06-11 | 20,000 | $6.72 | $134.4K | 20,000 | SEC↗ |
| WILLIAMS NICOLE | Director | A Award deriv | 2015-06-10 | 2015-06-11 | 20,000 | $6.72 | $134.4K | 20,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise deriv | 2015-03-13 | 2015-03-16 | 3,000 | $7.00 | $21.0K | 15,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise | 2015-03-13 | 2015-03-16 | 3,000 | $5.35 | $16.0K | 38,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | S Sale | 2015-03-13 | 2015-03-16 | 3,000 | $7.00 | $21.0K | 35,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise deriv | 2015-03-11 | 2015-03-13 | 2,000 | $6.83 | $13.7K | 6,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | S Sale | 2015-03-11 | 2015-03-13 | 2,000 | $6.83 | $13.7K | 35,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise | 2015-03-11 | 2015-03-13 | 2,000 | $5.33 | $10.7K | 37,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise deriv | 2015-03-03 | 2015-03-04 | 5,000 | $6.49 | $32.5K | 61,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | S Sale | 2015-03-03 | 2015-03-04 | 5,000 | $6.49 | $32.5K | 35,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise | 2015-03-03 | 2015-03-04 | 5,000 | $4.70 | $23.5K | 40,050 | SEC↗ |
| Baker Mark Robert | CEO | A Award deriv | 2015-03-02 | 2015-03-04 | 132,000 | $6.65 | $877.8K | 132,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | A Award deriv | 2015-03-02 | 2015-03-04 | 66,000 | $6.65 | $438.9K | 66,000 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2015-03-02 | 2015-03-04 | 15,342 | $6.65 | $102.0K | 15,342 | SEC↗ |
| Lovallo Angelo William JR | Vice President Finance | A Award deriv | 2015-03-02 | 2015-03-04 | 52,800 | $6.65 | $351.1K | 52,800 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise deriv | 2015-01-12 | 2015-01-13 | 2,000 | $7.06 | $14.1K | 8,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | S Sale | 2015-01-12 | 2015-01-13 | 2,000 | $7.06 | $14.1K | 35,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise | 2015-01-12 | 2015-01-13 | 2,000 | $5.33 | $10.7K | 37,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise deriv | 2014-12-11 | 2014-12-12 | 3,000 | $7.07 | $21.2K | 18,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise | 2014-12-11 | 2014-12-12 | 3,000 | $5.35 | $16.0K | 38,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | S Sale | 2014-12-11 | 2014-12-12 | 3,000 | $7.07 | $21.2K | 35,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise deriv | 2014-11-21 | 2014-11-21 | 9,000 | $7.00 | $63.0K | 21,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise | 2014-11-21 | 2014-11-21 | 9,000 | $5.35 | $48.1K | 44,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | S Sale | 2014-11-21 | 2014-11-21 | 9,000 | $7.00 | $63.0K | 35,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise deriv | 2014-11-13 | 2014-11-14 | 10,000 | $6.83 | $68.3K | 10,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | S Sale | 2014-11-13 | 2014-11-14 | 10,000 | $6.83 | $68.3K | 35,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise | 2014-11-13 | 2014-11-14 | 10,000 | $5.33 | $53.3K | 45,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise deriv | 2014-11-11 | 2014-11-12 | 5,000 | $6.53 | $32.6K | 55,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | M Exercise | 2014-11-11 | 2014-11-12 | 5,000 | $5.03 | $25.1K | 40,050 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | S Sale | 2014-11-11 | 2014-11-12 | 5,000 | $6.53 | $32.6K | 35,050 | SEC↗ |
| KOTLER KEVIN | 10% Owner | P Buy | 2014-07-21 | 2014-07-23 | 388,659 | $4.73 | $1.84M | 8,951,169 | SEC↗ |
| KOTLER KEVIN | 10% Owner | P Buy | 2014-07-18 | 2014-07-23 | 388,200 | $4.73 | $1.84M | 8,562,510 | SEC↗ |
| KOTLER KEVIN | 10% Owner | P Buy | 2014-07-17 | 2014-07-23 | 436,884 | $4.48 | $1.96M | 8,174,310 | SEC↗ |
| KOTLER KEVIN | 10% Owner | P Buy | 2014-07-16 | 2014-07-23 | 411,693 | $4.48 | $1.84M | 7,737,426 | SEC↗ |
| Crowley Peter J | Director | A Award deriv | 2014-06-17 | 2014-06-19 | 55,000 | $4.47 | $245.8K | 55,000 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2014-06-17 | 2014-06-19 | 20,000 | $4.47 | $89.4K | 20,000 | SEC↗ |
| MADDON PAUL J | Director | A Award deriv | 2014-06-17 | 2014-06-19 | 20,000 | $4.47 | $89.4K | 20,000 | SEC↗ |
| SCHEINBERG DAVID A | Director | A Award deriv | 2014-06-17 | 2014-06-19 | 20,000 | $4.47 | $89.4K | 20,000 | SEC↗ |
| WILLIAMS NICOLE | Director | A Award deriv | 2014-06-17 | 2014-06-19 | 20,000 | $4.47 | $89.4K | 20,000 | SEC↗ |
| Ferrante Karen Jean | Director | A Award deriv | 2014-06-17 | 2014-06-19 | 20,000 | $4.47 | $89.4K | 20,000 | SEC↗ |
| Baker Mark Robert | CEO | A Award deriv | 2014-03-03 | 2014-03-04 | 132,000 | $4.70 | $620.4K | 132,000 | SEC↗ |
| Youssoufian Hagop | Executive Vice President R&D | A Award deriv | 2014-03-03 | 2014-03-04 | 66,000 | $4.70 | $310.2K | 66,000 | SEC↗ |
| ISRAEL ROBERT J | Executive Vice President, Me | A Award deriv | 2014-03-03 | 2014-03-04 | 66,000 | $4.70 | $310.2K | 66,000 | SEC↗ |
| Lovallo Angelo William JR | Vice President Finance | A Award deriv | 2014-03-03 | 2014-03-04 | 52,800 | $4.70 | $248.2K | 52,800 | SEC↗ |
| Ferrante Karen Jean | Director | A Award deriv | 2014-01-29 | 2014-01-30 | 40,000 | $4.50 | $180.0K | 40,000 | SEC↗ |
| KISHBAUCH MICHAEL D | Director | A Award deriv | 2013-09-11 | 2013-09-12 | 40,000 | $5.91 | $236.4K | 40,000 | SEC↗ |
| Youssoufian Hagop | Executive Vice President R&D | A Award deriv | 2013-08-01 | 2013-08-08 | 150,000 | $5.84 | $876.0K | 150,000 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise deriv | 2013-07-18 | 2013-07-22 | 5,000 | $6.33 | $31.6K | 20,000 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | S Sale | 2013-07-18 | 2013-07-22 | 5,000 | $6.33 | $31.6K | 35,050 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise | 2013-07-18 | 2013-07-22 | 5,000 | $5.33 | $26.6K | 40,050 | SEC↗ |
| Crowley Peter J | Director | A Award deriv | 2013-06-12 | 2013-06-20 | 55,000 | $4.76 | $261.8K | 55,000 | SEC↗ |
| GOFF STEPHEN P | Director | A Award deriv | 2013-06-12 | 2013-06-20 | 20,000 | $4.76 | $95.2K | 20,000 | SEC↗ |
| MADDON PAUL J | Director | A Award deriv | 2013-06-12 | 2013-06-20 | 20,000 | $4.76 | $95.2K | 20,000 | SEC↗ |
| SCHEINBERG DAVID A | Director | A Award deriv | 2013-06-12 | 2013-06-20 | 20,000 | $4.76 | $95.2K | 20,000 | SEC↗ |
| WILLIAMS NICOLE | Director | A Award deriv | 2013-06-12 | 2013-06-20 | 20,000 | $4.76 | $95.2K | 20,000 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | A Award deriv | 2013-04-04 | 2013-04-08 | 60,000 | $5.03 | $301.8K | 60,000 | SEC↗ |
| Olson William C | Senior VP, Research and Deve | A Award deriv | 2013-04-04 | 2013-04-08 | 60,000 | $5.03 | $301.8K | 60,000 | SEC↗ |
| Baker Mark Robert | CEO | A Award deriv | 2013-04-04 | 2013-04-08 | 120,000 | $5.03 | $603.6K | 120,000 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2013-03-27 | 2013-03-28 | 50 | $5.34 | $267 | 161,041 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2013-03-27 | 2013-03-28 | 100 | $5.36 | $536 | 161,141 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2013-03-27 | 2013-03-28 | 500 | $5.31 | $2.7K | 160,991 | SEC↗ |
| SCHEINBERG DAVID A | Director | M Exercise | 2013-03-22 | 2013-03-22 | 1,250 | $4.81 | $6.0K | 46,185 | SEC↗ |
| SCHEINBERG DAVID A | Director | M Exercise | 2013-03-22 | 2013-03-22 | 1,250 | $2.47 | $3.1K | 47,435 | SEC↗ |
| SCHEINBERG DAVID A | Director | M Exercise deriv | 2013-03-21 | 2013-03-21 | 1,250 | $2.47 | $3.1K | 1,250 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2013-02-27 | 2013-02-28 | 227 | $2.75 | $624 | 160,491 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2013-02-27 | 2013-02-28 | 500 | $2.71 | $1.4K | 159,729 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2013-02-27 | 2013-02-28 | 535 | $2.72 | $1.5K | 160,264 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2013-01-22 | 2013-01-23 | 900 | $2.82 | $2.5K | 158,914 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2013-01-22 | 2013-01-23 | 315 | $2.83 | $891 | 159,229 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-12-26 | 2012-12-26 | 1,142 | $3.01 | $3.4K | 158,014 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-11-28 | 2012-11-30 | 100 | $2.13 | $213 | 155,765 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-11-28 | 2012-11-30 | 1,000 | $2.13 | $2.1K | 156,865 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-11-28 | 2012-11-30 | 100 | $2.13 | $213 | 155,865 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-11-28 | 2012-11-30 | 7 | $2.14 | $15 | 156,872 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-11-28 | 2012-11-30 | 100 | $2.12 | $212 | 155,665 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-11-28 | 2012-11-30 | 300 | $2.12 | $636 | 155,565 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-11-19 | 2012-11-20 | 11,800 | $1.96 | $23.1K | 155,265 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-11-16 | 2012-11-19 | 49,793 | $1.82 | $90.6K | 143,465 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-11-15 | 2012-11-16 | 48,833 | $1.69 | $82.5K | 93,672 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-10-24 | 2012-10-25 | 1,162 | $2.96 | $3.4K | 44,839 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-09-26 | 2012-09-27 | 1,036 | $3.32 | $3.4K | 43,677 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-08-22 | 2012-08-23 | 815 | $4.23 | $3.4K | 42,641 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-07-25 | 2012-07-26 | 346 | $10.04 | $3.5K | 41,826 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise deriv | 2012-07-02 | 2012-07-03 | 1,000 | $9.79 | $9.8K | 25,000 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise | 2012-07-02 | 2012-07-03 | 1,000 | $5.33 | $5.3K | 36,050 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | S Sale | 2012-07-02 | 2012-07-03 | 1,000 | $9.79 | $9.8K | 35,050 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-06-27 | 2012-06-29 | 75 | $9.21 | $691 | 41,180 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-06-27 | 2012-06-29 | 179 | $9.29 | $1.7K | 41,380 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-06-27 | 2012-06-29 | 100 | $9.29 | $929 | 41,480 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-06-27 | 2012-06-29 | 21 | $9.27 | $195 | 41,201 | SEC↗ |
| Olson William C | Senior VP, Research and Deve | D To issuer | 2012-06-20 | 2012-06-22 | 1,230 | $8.69 | $10.7K | 45,544 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | D To issuer | 2012-06-20 | 2012-06-22 | 3,333 | $8.58 | $28.6K | 35,050 | SEC↗ |
| Crowley Peter J | Director | A Award deriv | 2012-06-13 | 2012-06-14 | 40,000 | $7.93 | $317.2K | 40,000 | SEC↗ |
| WILLIAMS NICOLE | Director | A Award deriv | 2012-06-13 | 2012-06-14 | 10,000 | $7.93 | $79.3K | 10,000 | SEC↗ |
| SCHEINBERG DAVID A | Director | A Award deriv | 2012-06-13 | 2012-06-14 | 10,000 | $7.93 | $79.3K | 10,000 | SEC↗ |
| GOFF STEPHEN P | Director | A Award deriv | 2012-06-13 | 2012-06-14 | 10,000 | $7.93 | $79.3K | 10,000 | SEC↗ |
| BRINER KURT W | Director | A Award deriv | 2012-06-13 | 2012-06-14 | 10,000 | $7.93 | $79.3K | 10,000 | SEC↗ |
| BAKER CHARLES A | Director | A Award deriv | 2012-06-13 | 2012-06-14 | 10,000 | $7.93 | $79.3K | 10,000 | SEC↗ |
| MADDON PAUL J | Director | A Award deriv | 2012-06-13 | 2012-06-14 | 10,000 | $7.93 | $79.3K | 10,000 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise deriv | 2012-06-01 | 2012-06-04 | 1,000 | $8.51 | $8.5K | 26,000 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise | 2012-06-01 | 2012-06-04 | 1,000 | $5.33 | $5.3K | 39,383 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | S Sale | 2012-06-01 | 2012-06-04 | 1,000 | $8.51 | $8.5K | 38,383 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-05-23 | 2012-05-24 | 445 | $7.81 | $3.5K | 41,105 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise deriv | 2012-05-01 | 2012-05-03 | 1,000 | $10.93 | $10.9K | 27,000 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | S Sale | 2012-05-01 | 2012-05-03 | 1,000 | $10.93 | $10.9K | 38,383 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise | 2012-05-01 | 2012-05-03 | 1,000 | $5.33 | $5.3K | 39,383 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-04-25 | 2012-04-27 | 100 | $9.92 | $992 | 40,660 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-04-25 | 2012-04-27 | 133 | $10.25 | $1.4K | 40,445 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-04-25 | 2012-04-27 | 15 | $10.25 | $154 | 40,460 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-04-25 | 2012-04-27 | 100 | $9.97 | $997 | 40,560 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise deriv | 2012-04-02 | 2012-04-03 | 1,000 | $9.85 | $9.8K | 28,000 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | S Sale | 2012-04-02 | 2012-04-03 | 1,000 | $9.85 | $9.8K | 38,383 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise | 2012-04-02 | 2012-04-03 | 1,000 | $5.33 | $5.3K | 39,383 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-03-28 | 2012-03-29 | 100 | $10.00 | $1.0K | 40,172 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-03-28 | 2012-03-29 | 103 | $10.18 | $1.0K | 40,072 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-03-28 | 2012-03-29 | 140 | $10.19 | $1.4K | 40,312 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise deriv | 2012-03-01 | 2012-03-02 | 1,000 | $9.82 | $9.8K | 29,000 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | A Award deriv | 2012-03-01 | 2012-03-05 | 50,000 | $9.81 | $490.5K | 50,000 | SEC↗ |
| Olson William C | Senior VP, Research and Deve | A Award deriv | 2012-03-01 | 2012-03-05 | 50,000 | $9.81 | $490.5K | 50,000 | SEC↗ |
| MCKINNEY ROBERT A | Senior VP, CFO | A Award deriv | 2012-03-01 | 2012-03-05 | 50,000 | $9.81 | $490.5K | 50,000 | SEC↗ |
| Baker Mark Robert | CEO | A Award deriv | 2012-03-01 | 2012-03-05 | 66,666 | $9.81 | $654.0K | 66,666 | SEC↗ |
| Baker Mark Robert | CEO | A Award deriv | 2012-03-01 | 2012-03-05 | 33,334 | $9.81 | $327.0K | 100,000 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise | 2012-03-01 | 2012-03-02 | 1,000 | $5.33 | $5.3K | 39,383 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | S Sale | 2012-03-01 | 2012-03-02 | 1,000 | $9.82 | $9.8K | 38,383 | SEC↗ |
| SCHEINBERG DAVID A | Director | M Exercise deriv | 2012-02-23 | 2012-02-27 | 1,250 | $10.00 | $12.5K | 0 | SEC↗ |
| SCHEINBERG DAVID A | Director | M Exercise deriv | 2012-02-23 | 2012-02-27 | 1,250 | $6.90 | $8.6K | 1,250 | SEC↗ |
| SCHEINBERG DAVID A | Director | S Sale | 2012-02-23 | 2012-02-27 | 1,250 | $10.00 | $12.5K | 46,185 | SEC↗ |
| SCHEINBERG DAVID A | Director | M Exercise | 2012-02-23 | 2012-02-27 | 1,250 | $6.90 | $8.6K | 47,435 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-02-22 | 2012-02-23 | 166 | $9.40 | $1.6K | 39,766 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-02-22 | 2012-02-23 | 100 | $9.40 | $940 | 39,866 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-02-22 | 2012-02-23 | 2 | $9.42 | $19 | 39,868 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-02-22 | 2012-02-23 | 1 | $9.54 | $10 | 39,969 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-02-22 | 2012-02-23 | 100 | $9.45 | $945 | 39,968 | SEC↗ |
| BRINER KURT W | Director | S Sale | 2012-02-03 | 2012-02-03 | 33,000 | $10.22 | $337.3K | 0 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise deriv | 2012-02-01 | 2012-02-02 | 1,000 | $9.48 | $9.5K | 30,000 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise | 2012-02-01 | 2012-02-02 | 1,000 | $5.33 | $5.3K | 39,383 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | S Sale | 2012-02-01 | 2012-02-02 | 1,000 | $9.48 | $9.5K | 38,383 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-01-25 | 2012-01-26 | 4 | $9.50 | $38 | 39,307 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-01-25 | 2012-01-26 | 63 | $9.45 | $595 | 39,299 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-01-25 | 2012-01-26 | 100 | $9.56 | $956 | 39,600 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-01-25 | 2012-01-26 | 3 | $9.49 | $28 | 39,303 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-01-25 | 2012-01-26 | 1 | $9.45 | $9 | 39,300 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-01-25 | 2012-01-26 | 193 | $9.55 | $1.8K | 39,500 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-01-11 | 2012-01-12 | 200 | $8.87 | $1.8K | 39,236 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2012-01-11 | 2012-01-12 | 191 | $8.86 | $1.7K | 39,036 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise deriv | 2012-01-03 | 2012-01-04 | 1,000 | $8.78 | $8.8K | 31,000 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | M Exercise | 2012-01-03 | 2012-01-04 | 1,000 | $5.33 | $5.3K | 39,383 | SEC↗ |
| ISRAEL ROBERT J | Senior VP Medical Affairs | S Sale | 2012-01-03 | 2012-01-04 | 1,000 | $8.78 | $8.8K | 38,383 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2011-10-26 | 2012-01-12 | 1 | $6.53 | $7 | 37,680 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2011-10-26 | 2012-01-12 | 76 | $6.50 | $494 | 38,211 | SEC↗ |
| Baker Mark Robert | CEO | P Buy | 2011-10-26 | 2012-01-12 | 455 | $6.52 | $3.0K | 38,135 | SEC↗ |
| MADDON PAUL J | Director | P Buy | 2010-12-01 | 2016-04-22 | 5,000 | $4.90 | $24.5K | 909,891 | SEC↗ |